Inventor

Pingchen Fan

Inventor
Fremont, CA, US

Overview

39→
Patents
2004–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes27%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
10,828,285Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors202010,759,807Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors202010,759,7892-oxindole compounds202010,744,118Diazole lactams202010,683,2945-5 fused rings as C5a inhibitors202010,660,897C5aR antagonists202010,596,163Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides202010,562,8966-5 fused rings as C5a inhibitors202010,532,982Processes and intermediates in the preparation of C5aR antagonists202010,487,098Soluble C5aR antagonists201910,421,7482-oxindole compounds201910,342,781Diazole amides201910,329,314Soluble C5aR antagonists201910,266,492Processes and intermediates in the preparation of C5aR antagonists201910,137,120Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides201810,035,768C5aR antagonists20189,750,722'Diazole amides'20179,745,268'Processes and intermediates in the preparation of C5aR antagonists'20179,573,897'C5AR antagonists'20179,328,116'Diazole lactams'20169,181,241'Antagonists of chemokine receptors'20159,169,248'Diazole amides'20159,126,939'C5AR antagonists'20158,980,903'Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors'20158,916,601'Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides'20148,906,938'C5aR antagonists'20148,853,202'Modulators of CXCR7'20148,841,312'Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors'20148,445,515'C5aR antagonists'20138,389,533'Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors'20138,288,373'Modulators of CXCR7'20127,253,179'Fused heterocyclic compounds'20077,148,259'Antibacterial agents'20067,125,885'Fused heterocyclic compounds'20067,053,234'Antibacterial agents'20067,045,527'Piperidine derivatives'20066,858,619'Fused heterocyclic compounds'20056,809,104'Fused heterocyclic compounds'20046,780,858'Antibacterial agents'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2020Based in Fremont, CA, US· patent location history
2004–2006Based in Newark, CA, US· patent location history
2005–2015Patents assigned to AMGEN INC (9)· patent assignee history
2012–2020Patents assigned to CHEMOCENTRYX INC (27)· patent assignee history
2012–2015Patents assigned to FAN PINGCHEN (6)· patent assignee history
2012–2015Patents assigned to POWERS JAY (4)· patent assignee history
2012–2015Patents assigned to ZENG YIBIN (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CHEMOCENTRYX INC272012–2020
AMGEN INC92005–2015
FAN PINGCHENself62012–2015
POWERS JAY42012–2015
ZENG YIBIN42012–2015
Locations
LocationPatentsSpan
Fremont, California, US362004–2020
Newark, California, US32004–2006